LAURUS LABS
Quarterly Results Analysis [Jun2025]
LAURUS LABS Quarterly Results
Consolidated | Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹1,570 Cr | ₹1,720 Cr | ₹1,415 Cr | ₹1,224 Cr | ₹1,195 Cr | ₹1,440 Cr | ₹1,195 Cr | ₹1,224 Cr |
Expenses | ₹1,187 Cr | ₹1,300 Cr | ₹1,130 Cr | ₹1,045 Cr | ₹1,024 Cr | ₹1,198 Cr | ₹1,014 Cr | ₹1,037 Cr |
Operating Income | ₹382 Cr | ₹421 Cr | ₹285 Cr | ₹178 Cr | ₹171 Cr | ₹241 Cr | ₹181 Cr | ₹188 Cr |
Other Income | ₹10 Cr | ₹59 Cr | ₹9 Cr | ₹5 Cr | ₹3 Cr | ₹19 Cr | ₹2 Cr | ₹2 Cr |
Interest | ₹52 Cr | ₹56 Cr | ₹58 Cr | ₹53 Cr | ₹49 Cr | ₹51 Cr | ₹51 Cr | ₹42 Cr |
Depreciation | ₹117 Cr | ₹110 Cr | ₹106 Cr | ₹108 Cr | ₹106 Cr | ₹102 Cr | ₹98 Cr | ₹93 Cr |
Profit Before Tax | ₹224 Cr | ₹312 Cr | ₹131 Cr | ₹23 Cr | ₹18 Cr | ₹107 Cr | ₹35 Cr | ₹54 Cr |
Profit After Tax | ₹161 Cr | ₹234 Cr | ₹91 Cr | ₹18 Cr | ₹12 Cr | ₹75 Cr | ₹25 Cr | ₹39 Cr |
EPS | ₹3.02 | ₹4.33 | ₹1.71 | ₹0.37 | ₹0.23 | ₹1.40 | ₹0.43 | ₹0.69 |
Industry Peers & Returns | 1W | 1M | 1Y |
LAURUS LABS | 1.5% | 6.9% | 99.8% |
SUN PHARMACEUTICAL INDUSTRIES | 0.6% | -2.4% | -7% |
DIVIS LABORATORIES | -0.3% | -7.6% | 23% |
CIPLA | 1.8% | 8.1% | -0.1% |
TORRENT PHARMACEUTICALS | 0.9% | 3.7% | 8.9% |
DR REDDYS LABORATORIES | 1% | 2.4% | -9.6% |
MANKIND PHARMA | 5.5% | 0.2% | 14% |
ZYDUS LIFESCIENCES | 0.2% | 2.8% | -18.2% |
LUPIN | 0.3% | 2.9% | -7.3% |
LAURUS LABS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -8.76 % |
Y-o-Y | 31.35 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Jun2025 | ₹1,570 Cr | -8.76 | |
Mar2025 | ₹1,720 Cr | 21.57 | |
Dec2024 | ₹1,415 Cr | 15.64 | |
Sep2024 | ₹1,224 Cr | 2.41 | |
Jun2024 | ₹1,195 Cr | -17.00 | |
Mar2024 | ₹1,440 Cr | 20.48 | |
Dec2023 | ₹1,195 Cr | -2.41 | |
Sep2023 | ₹1,224 Cr | - |
LAURUS LABS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -9.15 % |
Y-o-Y | 123.21 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Jun2025 | ₹382 Cr | -9.15 | |
Mar2025 | ₹421 Cr | 47.50 | |
Dec2024 | ₹285 Cr | 59.90 | |
Sep2024 | ₹178 Cr | 4.16 | |
Jun2024 | ₹171 Cr | -29.11 | |
Mar2024 | ₹241 Cr | 33.11 | |
Dec2023 | ₹181 Cr | -3.43 | |
Sep2023 | ₹188 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -0.41 % |
Y-o-Y | 69.92 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Jun2025 | 24.35% | -0.41 | |
Mar2025 | 24.45% | 21.34 | |
Dec2024 | 20.15% | 38.30 | |
Sep2024 | 14.57% | 1.67 | |
Jun2024 | 14.33% | -14.55 | |
Mar2024 | 16.77% | 10.47 | |
Dec2023 | 15.18% | -1.04 | |
Sep2023 | 15.34% | - |
LAURUS LABS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -31.12 % |
Y-o-Y | 1,219.25 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Jun2025 | ₹161 Cr | -31.12 | |
Mar2025 | ₹234 Cr | 158.11 | |
Dec2024 | ₹91 Cr | 411.34 | |
Sep2024 | ₹18 Cr | 45.13 | |
Jun2024 | ₹12 Cr | -83.79 | |
Mar2024 | ₹75 Cr | 199.25 | |
Dec2023 | ₹25 Cr | -35.99 | |
Sep2023 | ₹39 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -24.50 % |
Y-o-Y | 905.88 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Jun2025 | 10.26 % | -24.50 | |
Mar2025 | 13.59 % | 112.34 | |
Dec2024 | 6.4 % | 341.38 | |
Sep2024 | 1.45 % | 42.16 | |
Jun2024 | 1.02 % | -80.50 | |
Mar2024 | 5.23 % | 147.87 | |
Dec2023 | 2.11 % | -34.27 | |
Sep2023 | 3.21 % | - |
LAURUS LABS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -30.25 % |
Y-o-Y | 1,213.04 % |
Quarters | EPS | % Change | |
---|---|---|---|
Jun2025 | ₹3.02 | -30.25 | |
Mar2025 | ₹4.33 | 153.22 | |
Dec2024 | ₹1.71 | 362.16 | |
Sep2024 | ₹0.37 | 60.87 | |
Jun2024 | ₹0.23 | -83.57 | |
Mar2024 | ₹1.4 | 225.58 | |
Dec2023 | ₹0.43 | -37.68 | |
Sep2023 | ₹0.69 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD